Ms. Lemson et al., Effects of a venous cuff at the venous anastomosis of polytetrafluoroethylene grafts for hemodialysis vascular access, J VASC SURG, 32(6), 2000, pp. 1155-1163
Citations number
54
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Introduction and Methods: The most frequent complication of polytetrafluoro
ethylene (PTFE) arteriovenous gafts for hemodialysis is thrombotic occlusio
n due to stenosis caused by intimal hyperplasia. This complication is also
known for peripheral bypass grafts. Because the use of a venous cuff at the
distal anastomosis improves the patency of peripheral bypass grafts, we co
nsidered that it might also improve the patency of PTFE arteriovenous graft
s. Therefore, a randomized multicenter trial was carried out to study the e
ffect of a venous cuff at the venous anastomosis of PTFE arteriovenous graf
ts on the development of stenoses and the patency rates.
Results: Of the 120 included patients, 59 were randomized for a venous cuff
. The incidence of thrombotic occlusion was lower in the cuff group (0.68 p
er patient-year) than in the no-cuff group (0.88 per patient-year; P = .000
7). However, the primary and secondary patency rates were comparable. The c
uff group tended to have fewer stenoses at the venous and arterial anastomo
ses when examined with duplex scan. Graft failure was higher in patients wi
th an initial anastomosing vein diameter smaller than 4 mm (7 of 18 [39%])
than in those with a vein diameter of 4 mm or larger (16 of 88 [18%]; P = .
052). Local edema, skin atrophy, and obesity yielded a higher risk on graft
failure (23% vs 11%).
Conclusion: A venous cuff at the venous anastomosis of PTFE arteriovenous g
rafts for hemodialysis reduced: the incidence of thrombotic occlusions; ste
nosis at the venous anastomosis was reduced. However, this did not result i
n a better patency rate. Therefore, the venous cuff should not be used rout
inely. Initial vein diameter and local problems (edema, obesity, or skin at
rophy) appear to be the most important risk factors for graft failure.